Treatment of chronic headache with antidepressants: a meta-analysis.

[1]  R. Badgett.  Review: antidepressants improve headache in patients with chronic headache , 2002, ACP journal club.

[2]  J. Jackson,et al.  Clinical predictors of mental disorders among medical outpatients. , 2001, Archives of internal medicine.

[3]  W F Stewart,et al.  Burden of migraine in the United States: disability and economic costs. , 1999, Archives of internal medicine.

[4]  P. O'Malley,et al.  Clinical predictors of mental disorders among medical outpatients. Validation of the "S4" model. , 1998, Psychosomatics.

[5]  K. Kroenke,et al.  Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. , 1997, The American journal of medicine.

[6]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[7]  C. Wallerstein.  US tobacco firms target Asia , 1997, BMJ.

[8]  N. Mathew,et al.  Transformed migraine, analgesic rebound, and other chronic daily headaches. , 1997, Neurologic clinics.

[9]  D. Barnes,et al.  Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone. , 1997, European neurology.

[10]  J. Olesen,et al.  A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[11]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[12]  K. Heininger,,et al.  Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings , 1994, Pain.

[13]  S. Silberstein,et al.  Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine , 1994, Headache.

[14]  K Kroenke,et al.  Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. , 1994, Archives of family medicine.

[15]  J. Olesen,et al.  Epidemiology of migraine and tension-type headache. , 1994, Current opinion in neurology.

[16]  A. Rapoport.  Recurrent migraine: Cost‐effective care , 1994, Neurology.

[17]  E. Scholz,et al.  Efficacy and Tolerability of Amitriptylinoxide in the Treatment of Chronic Tension-Type Headache: A Multi-Centre Controlled Study , 1994, Cephalalgia : an international journal of headache.

[18]  V. Manna,et al.  Chronic Tension‐Type Headache, Mood Depression and Serotonin: Therapeutic Effects of Fluvoxamine and Mianserine , 1994, Headache.

[19]  R. F. Nelson,et al.  Impact of Migraine and Tension-Type Headache on Life-Style, Consulting Behaviour, and Medication Use: A Canadian Population Survey , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[20]  B. Ansink,et al.  Ritanserin is not effective in tension headache , 1992, Headache.

[21]  Andrew L. Chesson,et al.  Fluoxetine Prophylaxis of Migraine , 1992, Headache.

[22]  W F Stewart,et al.  Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. , 1992, JAMA.

[23]  J. Olesen,et al.  Epidemiology of headache in a general population--a prevalence study. , 1991, Journal of clinical epidemiology.

[24]  A. Bellavance,et al.  A Comparative Study of Naproxen Sodium, Pizotyline and Placebo in Migraine Prophylaxis , 1990, Headache.

[25]  P Bech,et al.  Clomipramine and Mianserin in the Treatment of Chronic Tension Headache. A Double‐Blind, Controlled Study , 1990, Headache.

[26]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[27]  L. Knorring,et al.  Predictors for the outcome of treatment with antidepressants in patients with idiopathic pain syndromes , 1989 .

[28]  P. Carrieri,et al.  Amitriptyline in the treatment of headache in patients with Parkinson's disease , 1988, Neurology.

[29]  R F Galbraith,et al.  A note on graphical presentation of estimated odds ratios from several clinical trials. , 1988, Statistics in medicine.

[30]  Giuseppe Orefice,et al.  Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study , 1988, Cephalalgia : an international journal of headache.

[31]  S. Preskorn,et al.  Migraine prophylaxis. A comparison of propranolol and amitriptyline. , 1987, Archives of neurology.

[32]  V. Myllylä,et al.  Efficacy of Nimodipine in Comparison with Pizotifen in the Prophylaxis of Migraine , 1987, Cephalalgia : an international journal of headache.

[33]  I. Zeeberg,et al.  A randomized general practice * group‐comparative study of femoxetine and placebo in the prophylaxis of migraine , 1986, Acta neurologica Scandinavica.

[34]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[35]  R. Fogelholm,et al.  Maprotiline in Chronic Tension Headache: a Double‐blind Cross‐over Study , 1985, Headache.

[36]  A. Agnoli,et al.  Headache and noradrenergic involvement: the effects of α2‐stimulants and α2‐antagonists , 1985 .

[37]  A. Coppen,et al.  Mianserin in the prophylaxis of migraine: a double‐blind study , 1985, Acta psychiatrica Scandinavica. Supplementum.

[38]  H. Langohr,et al.  Clomipramine and Metoprolol in Migraine Prophylaxis — A Double‐blind Crossover Study , 1985, Headache.

[39]  A. Agnoli,et al.  Migraine and the Noradrenergic Control of Vasomotricity: A Study With Alpha‐2 Stimulant and Alpha‐2 Blocker Drugs , 1985, Headache.

[40]  N. Hendler.  Depression caused by chronic pain. , 1984, The Journal of clinical psychiatry.

[41]  V. Tuason,et al.  Relationship of Headaches to Depression , 1983, British Journal of Psychiatry.

[42]  O. Sjaastad.  So-Called “Tension Headache” — The Response to a 5-HT Uptake Inhibitor: Femoxetine , 1983, Cephalalgia : an international journal of headache.

[43]  H. Fields,et al.  Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system , 1983, Annals of Neurology.

[44]  N. Mathew,et al.  Transformation of Episodic Migraine Into Daily Headache: Analysis of Factors , 1982, Headache.

[45]  J J Larsen,et al.  Femoxetine in the prophylaxis of migraine ‐ A randomised comparison with placebo , 1981, Acta neurologica Scandinavica.

[46]  N. Mathew.  Prophylaxis of Migraine and Mixed Headache. A Randomized Controlled Study , 1981, Headache.

[47]  P. Dick,et al.  Antidepressants and serotonin neurons of the raphe. , 1981, Neuropsychobiology.

[48]  Noone Jf.  Clomipramine in the prevention of migraine. , 1980 .

[49]  T. Morland,et al.  Doxepin in the Prophylactic Treatment of Mixed ‘Vascular’ and Tension Headache , 1979, Headache.

[50]  J. Couch,et al.  Amitriptyline in migraine prophylaxis. , 1979, Archives of neurology.

[51]  P. Kangasniemi.  Placebo, 1‐Isopropylnoradrenochrome‐5‐Monosemicarbazono and Pizotifen in Migraine Prophylaxis , 1979, Headache.

[52]  R. Rosenthal.  The file drawer problem and tolerance for null results , 1979 .

[53]  B. Osuntokun,et al.  Pizotifen in the management of migraine. , 1978, The Practitioner.

[54]  R. Adams,et al.  Principles of Neurology , 1996 .

[55]  M. Hossain,et al.  Sanomigran for Migraine Prophylaxis; Controlled Multicenter Trial in General Practice , 1977, Headache.

[56]  K. Heathfield,et al.  Pizotifen in the treatment of migraine. , 1977, The Practitioner.

[57]  R. Cotton,et al.  VARIANT FORMS OF PHENYLKETONURIA , 1976, The Lancet.

[58]  J. Carroll,et al.  Pizotifen (BC 105) in migraine prophylaxis. , 1975, Current medical research and opinion.

[59]  J. D. Gomersall,et al.  Amitriptyline in migraine prophylaxis , 1973, Journal of neurology, neurosurgery, and psychiatry.

[60]  A. Okasha,et al.  A Double Blind Trial for the Clinical Management of Psychogenic Headache , 1973, British Journal of Psychiatry.

[61]  H. Jacobs.  A trial of opipramol in the treatment of migraine , 1972, Journal of neurology, neurosurgery, and psychiatry.

[62]  S. Diamond,et al.  CHRONIC TENSION HEADACHE‐TREATED WITH AMITRIPTYLINE‐A DOUBLE‐BLIND STUDY , 1971, Headache.

[63]  R. Ryan.  BC‐105 A NEW PREPARATION FOR THE INTERVAL TREATMENT OF MIGRAINE‐A DOUBLE BLIND EVALUATION COMPARED WITH A PLACEBO , 1971, Headache.

[64]  Hughes Rc,et al.  BC 105 in the prophylaxis of migraine. , 1971 .

[65]  Arthur Gp,et al.  The treatment of migraine with BC 105 (pizotifen): a double blind trial. , 1971 .

[66]  O. Sjaastad,et al.  APPRAISAL OF BC‐105 IN MIGRAINE PROPHYLAXIS , 1969, Acta neurologica Scandinavica.

[67]  R. Ryan.  DOUBLE‐BLIND CROSSOVER COMPARISON OF BC‐105, METHYSERGIDE AND PLACEBO IN THE PROHYLAXIS OF MIGRAINE HEADACHE , 1968 .

[68]  J. Lance,et al.  CLINICAL TRIAL OF A NEW SEROTONIN ANTAGONIST, BC105, IN THE PREVENTION OF MIGRAINE , 1968, The Medical journal of Australia.

[69]  J. Lance,et al.  TREATMENT OF CHRONIC TENSION HEADACHE. , 1964, Lancet.